Fig. 6

A–C correlation between the surrogate 5-gene model-predicted myeloid diversity and the original myeloid diversity in the TCGA, NCC, and METABRIC cohort. D–F Risk plots of surrogate myeloid diversity and their corresponding univariate cox regression results in the TCGA, NCC, and METABRIC cohort (y axis of top panel represents the predicted myeloid diversity, y axis of bottom panel represents the follow-up time, x axis represents different patients ranked by the predicted myeloid diversity, colors of top panel represent values of predicted myeloid diversity, colors of bottom panel represent progression status of patients). G Expression of the surrogate model genes in tumor and normal tissues, compared using transcriptomic data (y axis represents log-transformed expression of each gene, x axis represents different genes, colors represent tissue types). H Expression of the surrogate model genes in tumor and normal tissues, compared using immunohistochemistry (scale: 100 μm, target proteins were stained in brown)